Lonza Snares Novartis Contract | Chemical & Engineering News
Volume 86 Issue 29 | p. 24 | Concentrates
Issue Date: July 21, 2008

Lonza Snares Novartis Contract

Department: Business
News Channels: Environmental SCENE

Lonza has secured a long-term contract to help develop and manufacture biopharmaceuticals in Novartis' pipeline. Working out of its R&D center in Slough, England, the Swiss contract manufacturer will apply its gene expression system to Novartis drug candidates. Lonza will then make the drugs at sites in the U.S., Spain, and Singapore. The deal represents a shift from a typical contract arrangement to a more collaborative approach, and it gives Novartis extra capacity and technical support.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment